First Trust Nasdaq Pharmaceuticals ETF Rating → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free FTXH Stock Alerts $25.91 +0.06 (+0.23%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy2.56Holdings in FTXH have an aggregate rating of Moderate Buy based on 629 analyst ratings issued in the past year covering 50 companies (99.9% of the portfolio).FTXH Aggregate Price Target$32.1023.90% UpsideHigh Prediction$40.17Average Prediction$32.10Low Prediction$24.38Holdings in FTXH have an aggregate price target of $32.10 and a range of $24.38 to $40.17 covering 50 companies (99.9% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.58%MRKMerck & Co., Inc.$131.20+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst Revision7.35%PFEPfizer$25.40+0.6%5 of 5 stars2.38$36.33 43.0%16Upcoming EarningsDividend Announcement7.32%BMYBristol-Myers Squibb$44.85+0.3%5 of 5 stars2.11$60.00 33.8%19Earnings ReportAnalyst ReportAnalyst Revision7.19%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$176.08 10.3%13Earnings Report6.95%JNJJohnson & Johnson$146.14-0.5%5 of 5 stars2.46$175.86 20.3%133.81%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings3.69%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$297.40 10.2%19Upcoming Earnings3.66%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming Earnings3.64%CAHCardinal Health$103.21-0.6%4 of 5 stars2.55$103.07 -0.1%11Upcoming Earnings3.60%VRTXVertex Pharmaceuticals$397.48-0.1%4 of 5 stars2.48$429.45 8.0%23Upcoming Earnings3.56%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming Earnings3.53%GILDGilead Sciences$65.42+0.2%5 of 5 stars2.35$83.87 28.2%17Earnings ReportDividend AnnouncementAnalyst ReportShort Interest ↓Analyst Revision3.46%VTRSViatris$11.57+0.9%0 of 5 stars1.33$11.00 -4.9%33.38%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportShort Interest ↓Analyst Revision3.10%JAZZJazz Pharmaceuticals$109.46+1.9%5 of 5 stars2.85$195.08 78.2%13Upcoming Earnings2.97%ZTSZoetis$158.42+3.3%5 of 5 stars3.00$218.00 37.6%7Upcoming Earnings2.72%OGNOrganon & Co.$18.55+0.7%5 of 5 stars2.50$21.80 17.5%4Upcoming Earnings2.05%CRLCharles River Laboratories International$229.03+0.5%5 of 5 stars2.64$253.23 10.6%11Short Interest ↑1.47%PRGOPerrigo$31.94+2.1%5 of 5 stars3.00$40.67 27.3%3Positive News1.45%MEDPMedpace$395.93+1.6%5 of 5 stars2.80$443.00 11.9%5Earnings ReportAnalyst Revision1.26%HALOHalozyme Therapeutics$38.57+0.3%5 of 5 stars2.86$53.29 38.2%70.98%INCYIncyte$51.68+1.0%5 of 5 stars2.44$75.50 46.1%16Upcoming Earnings0.96%ALKSAlkermes$24.68+1.0%5 of 5 stars2.50$35.38 43.3%10Upcoming EarningsShort Interest ↓0.94%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst Revision0.88%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsShort Interest ↓0.83%PBHPrestige Consumer Healthcare$70.47+0.5%4 of 5 stars2.50$110.00 56.1%2Upcoming EarningsPositive News0.73%ELANElanco Animal Health$13.26+1.7%4 of 5 stars2.57$16.71 26.1%7Short Interest ↑0.60%ILMNIllumina$122.28+1.0%5 of 5 stars2.32$167.70 37.1%19Upcoming EarningsPositive News0.59%EXASExact Sciences$58.85+0.1%4 of 5 stars2.86$97.44 65.6%14Short Interest ↑Positive News0.56%BMRNBioMarin Pharmaceutical$80.91-1.5%5 of 5 stars2.63$107.50 32.9%19Analyst ReportShort Interest ↑Analyst Revision0.56%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst Revision0.55%KRYSKrystal Biotech$156.88+0.8%4 of 5 stars3.00$171.00 9.0%9Upcoming Earnings0.53%ACLXArcellx$51.92+1.1%3 of 5 stars3.00$75.64 45.7%12Short Interest ↑0.51%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up0.49%ROIVRoivant Sciences$11.03+1.4%4 of 5 stars2.90$16.90 53.2%10Short Interest ↑0.49%SRPTSarepta Therapeutics$128.77+1.1%4 of 5 stars2.79$156.60 21.6%14Upcoming Earnings0.48%IONSIonis Pharmaceuticals$41.59-0.6%4 of 5 stars2.69$56.08 34.8%13Positive News0.47%MLTXMoonLake Immunotherapeutics$42.49+0.6%3 of 5 stars2.75$74.46 75.2%12Positive News0.47%RYTMRhythm Pharmaceuticals$38.28+0.3%2 of 5 stars3.00$47.20 23.3%5Analyst Report0.45%IDYAIDEAYA Biosciences$39.94+3.4%3 of 5 stars3.00$46.60 16.7%120.45%RAREUltragenyx Pharmaceutical$44.24+0.9%4 of 5 stars2.92$88.08 99.1%12Upcoming Earnings0.45%VKTXViking Therapeutics$74.31+7.9%5 of 5 stars3.00$112.25 51.1%10Earnings ReportAnalyst Revision0.45%MRUSMerus$45.04+0.2%2 of 5 stars3.00$56.33 25.1%11Upcoming EarningsAnalyst Revision0.44%KYMRKymera Therapeutics$33.37+0.1%1 of 5 stars2.54$41.20 23.5%13Upcoming Earnings0.44%TGTXTG Therapeutics$13.47-3.2%4 of 5 stars2.83$29.00 115.3%6Upcoming Earnings0.40%NUVLNuvalent$66.86+1.2%3 of 5 stars2.90$90.78 35.8%100.40%ARVNArvinas$32.37+2.4%3 of 5 stars2.88$59.73 84.5%16Upcoming Earnings0.39%ACADACADIA Pharmaceuticals$16.71+2.5%4 of 5 stars2.80$32.13 92.3%150.36%CRSPCRISPR Therapeutics$53.91+0.3%3 of 5 stars2.38$76.29 41.5%160.33%BEAMBeam Therapeutics$21.38-1.0%2 of 5 stars2.38$41.00 91.8%13 This page (NASDAQ:FTXH) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMan Who Predicted 2008: “This Will be Worse.”AltimetryThe World's First "$20 Trillion Drug?"Behind the MarketsGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
